P
Philippe Moreau
Researcher at University of Nantes
Publications - 693
Citations - 52995
Philippe Moreau is an academic researcher from University of Nantes. The author has contributed to research in topics: Multiple myeloma & Medicine. The author has an hindex of 104, co-authored 517 publications receiving 42530 citations. Previous affiliations of Philippe Moreau include University of Grenoble & National and Kapodistrian University of Athens.
Papers
More filters
Journal ArticleDOI
P-259: Ciltacabtagene autoleucel (cilta-cel) versus real world clinical practice in triple-class exposed multiple myeloma: adjusted comparison of patient reported outcomes from CARTITUDE-1 and LocoMMotion
Maria-Victoria Mateos,Katja Weisel,Laure Vincent,Thomas Martin,Jesus G. Berdeja,Andrzej Jakubowiak,Sundar Jagannath,Yi Lin,P. Thilakarathne,Francesca Ghilotti,Joris Diels,Benjamin Haefliger,Clare Hague,Ailish Gonzalez,Jordan M. Schecter,Katharine S. Gries,Vadim Strulev,Tonia Nesheiwat,Lida Bubuteishvili Pacaud,Hermann Einsele,Philippe Moreau +20 more
Journal ArticleDOI
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma. Iskpd - IFM2018-03
Arthur Bobin,Jérôme Lambert,Stéphanie Ragot,Aurore Perrot,Salomon Manier,Lionel Karlin,Denis Caillot,Cyrille Hulin,Lotfi Benboubker,Carla Araujo,Jean Fontan,Thorsten Braun,Clara Mariette,Elodie Scherman,Olivier Decaux,Jean-Sébastien Bladé,Faida Keddar,C. Roul,Mamoun Dib,Jill Corre,Frederique Orsini,Laure Vincent,Mohamad Mohty,Cyrille Touzeau,Philippe Moreau,Herve Avet Loiseau,Xavier Leleu +26 more
TL;DR: In this article , a phase II multicentric, open-label study of isatuximab (anti-CD38 IT), pomalidomide and dexamethasone plus carfilzomib (IsKPd/IFM2018-03, NCT04287855) for patients with early relapse multiple myeloma was presented.
Journal ArticleDOI
OAB-012: Early and sustained negative minimal residual disease (MRDneg) after idecabtagene vicleucel (ide-cel) defines a subset of multiple myeloma (MM) patients in KarMMa achieving prolonged survival
Bruno Paiva,Irene Manrique,Julie A. Rytlewski,Timothy B. Campbell,Christian C. Kazanecki,Nathan Martin,Shari Kaiser,Larry D. Anderson,Jesus G. Berdeja,Sagar Lonial,Noopur Raje,Yi Lin,Philippe Moreau,Jesús F. San Miguel,Nikhil C. Munshi +14 more
Journal ArticleDOI
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis.
Yawara Kawano,Ki-Hyun Kim,Chang-Ki Min,Youngil Koh,Kenichi Ishizawa,Sung Hyun Kim,Shigeki Ito,Junji Tanaka,Michihiro Uchiyama,Tadao Ishida,Jin Seok Kim,Philippe Moreau,Thomas Martin,K. Tada,Marie-Laure Risse,Kenshi Suzuki +15 more